AvePoint, Inc.·4

Jun 23, 5:05 PM ET

Gong Xunkai 4

4 · AvePoint, Inc. · Filed Jun 23, 2026

Research Summary

AI-generated summary of this filing

Updated

AvePoint (AVPT) Executive Chairman Gong Xunkai Exercises Options

What Happened

  • Gong Xunkai, AvePoint's Executive Chairman and Director, exercised options/converted derivatives on June 22, 2026 to acquire a total of 949,442 shares (205,913 + 743,529) at an exercise price of $9.97 per share. The cash paid for the exercises was about $9,465,937 in the aggregate. The filing also shows corresponding disposals of the derivative instruments at $0, which reflect the conversion/cancellation of those derivatives upon settlement.

Key Details

  • Transaction date: 2026-06-22; filing date: 2026-06-23 (appears timely).
  • Shares acquired via exercise: 205,913 and 743,529 at $9.97 each (total 949,442 shares); aggregate cash paid ≈ $9,465,937.
  • Disposals recorded at $0 for the same lot sizes reflect conversion/cancellation of the derivative instruments upon settlement.
  • Footnotes: F1/F2 = RSUs and common stock reporting (RSUs convert to one share on vesting); F3 = options granted under the 2016 Equity Incentive Plan were exercised.
  • Shares owned after transaction: not specified in the excerpt provided—see the full Form 4 (Table I) for total holdings.

Context

  • Code M transactions indicate option exercises/conversions of derivatives. There is no evidence in this filing that the acquired shares were immediately sold; this appears to be an exercise/settlement rather than an open-market sale. Exercises and RSU conversions result in share ownership but do not necessarily signal the insider's market timing or longer-term intent.

Insider Transaction Report

Form 4
Period: 2026-06-22
Gong Xunkai
DirectorExecutive Chairman
Transactions
  • Exercise/Conversion

    Common Stock

    [F1][F2]
    2026-06-22$9.97/sh+205,913$2,052,9531,125,503 total
  • Exercise/Conversion

    Common Stock

    [F1][F2]
    2026-06-22$9.97/sh+743,529$7,412,9841,869,032 total
  • Exercise/Conversion

    Stock Option (Right to Buy)

    [F3]
    2026-06-22205,9135,369,222 total
    Exercise: $1.34From: 2020-07-01Exp: 2026-07-01Common Stock (205,913 underlying)
  • Exercise/Conversion

    Stock Option (Right to Buy)

    [F3]
    2026-06-22743,5294,625,693 total
    Exercise: $1.34From: 2020-07-01Exp: 2026-07-01Common Stock (743,529 underlying)
Footnotes (3)
  • [F1]This security represents the Issuer's common stock as well as restricted stock units (each, an "RSU") granted to the Reporting Person under the Issuer's 2021 Equity Incentive Plan. Each RSU represents the contingent right to receive, upon vesting of the RSU, one share of the Issuer's common stock.
  • [F2]Includes non-RSU common stock as well as aggregate vested and unvested RSUs held by the Reporting Person subject to the vesting schedules previously reported on Table I of Form 4s filed with the Securities and Exchange Commission on September 3, 2021, March 22, 2022, March 23, 2023, March 7, 2024, March 18, 2025, and March 18, 2026.
  • [F3]This security represents options to purchase the Issuer's common stock granted to the Reporting Person under the Issuer's 2016 Equity Incentive Plan that have been exercised.
Signature
/s/ Brian Michael Brown, Attorney-in-Fact|2026-06-23

Documents

1 file
  • 4
    rdgdoc.xmlPrimary

    FORM 4